EP Patent

EP1389209B1 — Folate mimetics and folate-receptor binding conjugates thereof

Assigned to Purdue Research Foundation · Expires 2009-04-08 · 17y expired

What this patent protects

This present disclosure relates to folate mimetics and their use in therapeutic and diagnostic applications. More particularly, the disclosure relates to using des-glutamyl folic acid analogs recognized by and selectively bound by folate receptors and other folate binding protein…

USPTO Abstract

This present disclosure relates to folate mimetics and their use in therapeutic and diagnostic applications. More particularly, the disclosure relates to using des-glutamyl folic acid analogs recognized by and selectively bound by folate receptors and other folate binding proteins and the use of such analogs for targeted delivery of diagnostic or therapeutic agents to folate-receptor bearing cell populations.

Drugs covered by this patent

Patent Metadata

Patent number
EP1389209B1
Jurisdiction
EP
Classification
—
Expires
2009-04-08
Drug substance claim
No
Drug product claim
No
Assignee
Purdue Research Foundation
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.